Advances in immuno-based and targeted therapies in extensive-stage small cell lung cancer
Immunotherapy now plays a key role in supplementing and even replacing conventional agents in tumor treatment. Immune checkpoint inhibitors (ICIs), represented by atezolizumab and durvalumab, have shown encouraging therapeutic effects in the combination chemotherapy for extensive-stage small cell lu...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
SAGE Publishing
2025-07-01
|
| Schriftenreihe: | Therapeutic Advances in Medical Oncology |
| Online-Zugang: | https://doi.org/10.1177/17588359251359057 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!